Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Sunitinib (SU11248) in Patients With Kaposi's Sarcoma in East Africa

NCT00521092 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00521092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00521092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Sunitinib (SU11248) in Patients With Kaposi's Sarcoma in East Africa
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 2009
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aids-related kaposi sarcoma, classic kaposi sarcoma